Ajax Therapeutics Funding & Investors
New York, NY
Ajax is targeting hematologic malignancies with greater precision by applying state-of-the-art computational chemistry and structural biology throughout the drug discovery and development process to create best-in-class therapies for significant unmet medical needs.
ajaxtherapeutics.comTotal Amount Raised: $143,000,000
Ajax Therapeutics Funding Rounds
Series C
$95,000,000
Series C Investors
Goldman Sachs Asset ManagementSchrodingerPoint72 VenturesEli LillyInning One VenturesBoxer CapitalRa Capital ManagementVivo CapitalEcoR1 CapitalSeries Unknown
$40,000,000
Series Unknown Investors
EcoR1 CapitalMemorial Sloan Kettering Cancer CenterBoxer CapitalInning One VenturesSchrodingerNYU Langone HealthSeries Unknown
$8,000,000
Funding info provided by Diffbot.